Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons

NeuroReport

Volumn 18, Issue 1, 2007, Pages 77-79

  Knudsen, Stine ^a   Mikkelsen, Jens D ^b   Jennum, Poul ^a  

^a GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

Autoantibodies; Hypothalamus; Immunohistochemistry; Narcolepsy cataplexy; Orexin

Indexed keywords

ANTIBODY; OREXIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; CATAPLEXY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HYPOTHALAMUS; IMMUNOCHEMISTRY; MALE; NARCOLEPSY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; STAINING;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NARCOLEPSY; NEURONS; NEUROPEPTIDES; RATS;

EID: 33846656059     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e328010baad     Document Type: Article

References (16)

1. Nishino S, Kanbayashi T. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/ orexin system. Sleep Med Rev 2005; 9:269-310.
2. de Lecea L, Sutcliffe JG. The hypocretins and sleep. FEBS J 2005; 272:5675-5688.
3. Peyron C, Faraco J, Rogers W, Ripley B, Overeem S, Charnay Y, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000; 6:991-997.
4. Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000; 27:469-474.
5. Black III JL. Narcolepsy: a review of evidence for autoimmune diathesis. Int Rev Psychiatry 2005; 17:461-469.
6. Dauvilliers Y, Tafti M. Molecular genetics and treatment of narcolepsy. Ann Med 2006; 38:252-262.
7. Mignot E, Lin L, Rogers W, Honda Y, Qiu X, Lin X, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001; 68:686-699.
8. Dauvilliers Y. Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol 2006; 60:153.
9. Mikkelsen JD, Hauser F, deLecea L, Sutcliffe JG, Kilduff TS, Calgari C, et al. Hypocretin (orexin) in the rat pineal gland: a central transmitter with effects on noradrenaline-induced release of melatonin. Eur J Neurosci 2001; 14:419-425.
10. Mikkelsen JD, Larsen PJ, Sørensen GG, Woldbye D, Bolwig TG, Hastings MH, et al. A dual-immunocytochemical method to localize c-fos protein in specific neurons based on their content of neuropeptides and connectivity. Histochemistry 1994; 101:245-251.
11. Larsen PJ, Mikkelsen JD. Vasoactive intestinal peptide (VIP) in magnocellular neurons of the hypothalamo-neurohypophysial system of the mink (Mustela vision) is co-localized with vasopressin or oxytocin. J Comp Neurol 1992; 326:180-192.
12. Black III JL, Silber MH, Krahn LE, Fredrickson PA, Pankratz VS, Avula R, et al. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep 2005; 28:427-431.
13. Overeem S, Verschuuren JJ, Fronczek R, Schreurs L, den Hertog H, Hegeman-Kleinn IM, et al. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy. J Neuroimmunol 2006; 174:187-191.
14. Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ. Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Neurosci Lett 2003; 341:13-16.
15. Tanaka S, Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep 2006; 29:633-638.
16. Waterman SA, Gordon TP, Rischmueller M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43:1647-1654.